Kalytera Therapeutics Appoints Robert Farrell as President and Chief Financial Officer
MANHATTAN BEACH, CA -- (Marketwired) -- 06/29/16 -- Kalytera Therapeutics, Inc., a pharmaceutical company developing a portfolio of proprietary cannabinoid and endocannabinoid-like medicines, today announced the appointment of Robert Farrell as Kalytera…